Guardant Health Inc (GH)
17.64
+0.06
(+0.31%)
USD |
NASDAQ |
Apr 23, 13:38
Guardant Health Revenue (TTM): 563.95M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 563.95M |
| September 30, 2023 | 535.78M |
| June 30, 2023 | 510.16M |
| March 31, 2023 | 482.15M |
| December 31, 2022 | 449.54M |
| September 30, 2022 | 430.76M |
| June 30, 2022 | 408.13M |
| March 31, 2022 | 391.09M |
| December 31, 2021 | 373.65M |
| September 30, 2021 | 343.86M |
| June 30, 2021 | 323.65M |
| March 31, 2021 | 297.88M |
| Date | Value |
|---|---|
| December 31, 2020 | 286.73M |
| September 30, 2020 | 271.31M |
| June 30, 2020 | 257.59M |
| March 31, 2020 | 245.23M |
| December 31, 2019 | 214.38M |
| September 30, 2019 | 184.35M |
| June 30, 2019 | 145.20M |
| March 31, 2019 | 110.60M |
| December 31, 2018 | 90.64M |
| September 30, 2018 | 77.77M |
| June 30, 2018 | 67.21M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
145.20M
Minimum
Jun 2019
563.95M
Maximum
Dec 2023
353.44M
Average
343.86M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Exact Sciences Corp | 2.500B |
| Illumina Inc | 4.504B |
| Delcath Systems Inc | 2.065M |
| CytoSorbents Corp | 31.08M |
| Progyny Inc | 1.089B |